I have no problem with BUBs and expect the SP to appreciate but it needs to significantly increase its revenues before it can justify its MC based on earning. Speculation is justified in that stock imo.
JAT's Q2,3 AND 4 numbers justify its current MC. JAT is the quiet achiever. Profit is king. Eventually the sheep will follow.
BTW I just checked the JD site.
Neurio is back on page 2 of 211 pages of JD's Mother and Baby/ Nutritional supplements section after restocking. Little ol' JAT is punching well above its weight. Go you good thing.
Ann: Acquisition of 70% of Australian Infant Formula Manufacturer, page-750
-
- There are more pages in this discussion • 300 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.5¢ |
Change
-0.045(6.16%) |
Mkt cap ! $57.45M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 71.0¢ | 68.5¢ | $18.75K | 27.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11795 | 68.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.5¢ | 7734 | 2 |
View Market Depth
| Last trade - 15.46pm 26/08/2024 (20 minute delay) ? |
| JAT (ASX) Chart |